Search

everythinglearnresearchcommunity

for

Search:↓

Nociplastic type pain, common in Chronic Overlapping Pain Conditions, is a complex, heritable trait linked to 24 unique genetic factors and 127 genes, with potential shared mechanisms in cognitive, personality, and metabolic traits.

Diagnosing and managing Glucocorticoid Resistance Syndrome is complex due to genetic differences and varied symptoms.

Rhupus is a complex syndrome that combines rheumatoid arthritis and lupus, making diagnosis challenging.

Nociplastic pain is a complex, heritable trait with genetic links to chronic and neuropathic pain.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

RAPK is a rare skin disorder with pigmented spots, mainly on hands and feet, starting in youth.

Parry–Romberg Syndrome can involve the brain even without obvious symptoms, and a new diagnostic framework is suggested for early detection.

A new mutation in the TRPS1 gene caused Trichorhinophalangeal syndrome in a 17-year-old, highlighting the need for genetic testing.

Rhupus is a complex syndrome that is hard to diagnose due to unclear clinical criteria.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Clear definitions and strategies are needed to manage long-term COVID-19 symptoms effectively.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

Traditional Chinese medicine may help relieve symptoms of Cronkhite-Canada syndrome.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

A new mutation in the TRPS1 gene was found in a Ukrainian girl with Trichorhinophalangeal syndrome type I.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

A young woman with severe symptoms of CPAN improved with intensive treatment but needed a leg amputation.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

Early diagnosis and treatment with corticosteroids can improve outcomes in Cronkhite–Canada syndrome.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Low TRPS1 expression in skin and hair cells is linked to hair problems in Trichorhinophalangeal syndrome.

Cronkhite-Canada syndrome is a rare condition causing gut polyps, hair loss, skin changes, and nail issues, often with a poor outlook.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Early diagnosis and nutritional support are crucial for managing Cronkhite-Canada Syndrome.